Red Tortoise LLC Enlivex Therapeutics Ltd. Transaction History
Red Tortoise LLC
- $192 Million
- Q4 2024
A detailed history of Red Tortoise LLC transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Red Tortoise LLC holds 150 shares of ENLV stock, worth $157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$157
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ENLV
# of Institutions
26Shares Held
2.59MCall Options Held
20.8KPut Options Held
3K-
Armistice Capital, LLC New York, NY2.14MShares$2.25 Million0.06% of portfolio
-
Morgan Stanley New York, NY246KShares$258,0410.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny74.8KShares$78,5280.0% of portfolio
-
Sigma Investment Counselors Inc28KShares$29,4000.0% of portfolio
-
Xtx Topco LTD London, X022.7KShares$23,7910.0% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $19.3M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...